Dusp5, transcriptionally inhibited by SOX11, inhibits Th2 differentiation in CD4+ T cells: a promising therapeutic target for allergic rhinitis
Experimental Animals · 2025
DOI: 10.1538/expanim.25-0076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Animals, 2025. Verfasst von Li Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District,…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Dual-Specificity Phosphatases, Th2 Cells, Cell Differentiation. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Allergic rhinitis (AR) is an inflammatory disorder driven primarily by aberrant T helper 2 (Th2) differentiation in CD4+ T cells. Although dual-specificity phosphatase 5 (DUSP5) has been implicated in inflammatory and autoimmune regulation, its role in AR remains unexplored. In this study, an AR mouse model was established via intraperitoneal sensitization and intranasal challenge with ovalbumin. We observed significant downregulation of DUSP5 expression in the nasal mucosa, particularly within CD4+ cells. To elucidate its function, a lentiviral vector overexpressing DUSP5 was constructed and used to transduce naive CD4+ T cells isolated from BALB/c mouse spleens. Overexpression of DUSP5 suppressed Th2-specific cytokine production and inhibited Th2 differentiation. Mechanistic investigations using a luciferase reporter assay revealed that Dusp5 is transcriptionally repressed by SRY-box transcription factor 11 (SOX11), a known transcription factor that promotes the progression of AR. Furthermore, DUSP5 overexpression counteracted the pro-Th2 effects mediated by SOX11. These results demonstrate that DUSP5, transcriptionally inhibited by SOX11, attenuates AR-associated inflammation by restraining Th2 differentiation. Our findings identify DUSP5 as a potential therapeutic target for AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang, 150001, P.R. China.
- Department of Otolaryngology Head and Neck Surgery, the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, 411 Gogol Street, Nangang District, Harbin, Heilongjiang, 150001, P.R. China.
Zitieren
APA
Jiang, L., Wang, C., Han, W., Xu, S., & Hu, Q. (2025). Dusp5, transcriptionally inhibited by SOX11, inhibits Th2 differentiation in CD4+ T cells: a promising therapeutic target for allergic rhinitis. Experimental Animals. https://doi.org/10.1538/expanim.25-0076
Vancouver
Jiang L, Wang C, Han W, Xu S, Hu Q. Dusp5, transcriptionally inhibited by SOX11, inhibits Th2 differentiation in CD4+ T cells: a promising therapeutic target for allergic rhinitis. Experimental Animals. 2025. doi:10.1538/expanim.25-0076
BibTeX
@article{Jiang2025,
author = {Jiang, Li and Wang, Chunrui and Han, Wei and Xu, Shijia and Hu, Qi},
title = {Dusp5, transcriptionally inhibited by SOX11, inhibits Th2 differentiation in CD4+ T cells: a promising therapeutic target for allergic rhinitis},
journal = {Experimental Animals},
year = {2025},
doi = {10.1538/expanim.25-0076}
}
EUVIMED